NSE · AMBANIORGO
Ambani Orgochem Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹244 Cr with net profit ₹1 Cr — a 0.55% net margin, versus -0.44% the period before.
Shareholding
As of 2026-09-30
- Promoter52.59%
- Public47.41%
280 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.05× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — ESM · ESM 1 · T2T. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Chemicals · ranked #1 of 161 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Solar Industries India Ltd. | ₹1,74,990 Cr | 77.31 | 22.63 | 29.5% | 17.7% |
| Pidilite Industries Ltd. | ₹1,55,399 Cr | 57.9 | 13.88 | 23.94% | 16.63% |
| SRF Ltd. | ₹73,365 Cr | 31.06 | 4.79 | 14.92% | 12.76% |
| Linde India Limited | ₹58,424 Cr | 118.21 | 13.31 | 11.26% | 18.08% |
| Gujarat Fluorochemicals Ltd. | ₹51,762 Cr | 75.93 | 6.17 | 7.97% | 11.43% |
| Navin Fluorine International Ltd. | ₹51,325 Cr | 56.02 | 11.53 | 20.41% | 22.4% |
| Godrej Industries Ltd. | ₹37,631 Cr | 30.76 | 3.38 | 12.38% | 5.85% |
| Himadri Speciality Chem Limited | ₹28,241 Cr | 33.04 | 5.5 | 16.65% | 15.28% |
| Aether Industries Limited | ₹22,263 Cr | 88.32 | 8.58 | 9.61% | 19.21% |
| Deepak Nitrite Ltd. | ₹21,747 Cr | 20.3 | 3.36 | 16.4% | 10.9% |
| Ambani Orgochem Limited(this company) | — | 110.11 | 3.08 | 2.43% | 0% |
AI analysis
AI-generated · google/gemini-2.5-flashAmbani Orgochem Limited (AMBANIORGO) is listed in the Chemicals sector. As of March 2025, the company reported revenue of Rs 193.93 Cr and a net loss of Rs 1.54 Cr, resulting in an EPS of -2.11. The debt-to-equity ratio was 1.00. The promoter holding stood at 54.30% as of June 2026.
Positives
- +Revenue grew to Rs 193.93 Cr in March 2025 from Rs 87.36 Cr in March 2021.
- +The company's promoter holding of 54.30% is above 50%, indicating significant insider confidence.
Negatives
- −The company reported a net loss of Rs 1.54 Cr in March 2025.
- −The EPS declined to -2.11 in March 2025 from 3.48 in March 2024.
- −The profit margin is 0%, indicating no net profit margin.
- −The debt-to-equity ratio of 1.00 suggests the company is equally financed by debt and equity.
Financial performance
Ambani Orgochem Limited's revenue has shown growth over recent years, reaching Rs 193.93 Cr in March 2025 from Rs 87.36 Cr in March 2021. However, the company reported a net loss of Rs 1.54 Cr in March 2025, a decrease from a net profit of Rs 3.04 Cr in March 2024. Earnings per share (EPS) moved from 1.07 in March 2023 to 3.48 in March 2024, and then to -2.11 in March 2025.
Profitability & returns
The company's return on equity (ROE) was 243.17% and return on capital employed (ROCE) was 6.59%. The profit margin for the latest reported period was 0%. The EPS for March 2025 was -2.11, compared to 3.48 in March 2024. EBITDA was Rs 7.72 Cr in March 2025.
Balance sheet
The company's debt-to-equity ratio is 1.00. The book value per share is Rs 63.33. No information regarding quarterly results was provided to evaluate recent balance sheet changes.
Ownership & pledges
As of June 2026, promoters held 54.30% of the shares. Public shareholding was 45.70%. The number of shareholders increased to 284 in June 2026 from 227 in November 2021. There was no promoter pledging reported.
Data as of — price: 2026-11-14 · financials: Mar 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.